More News

10 Oct 2019 Alexion and Stealth Announce Agreement for Option to Co-Develop and Commercialize Late-Stage Therapy for Mitochondrial Diseases
10 Oct 2019 Bayer and RIKEN Innovation establish partnership in drug discovery
10 Oct 2019 Avacta Group plc Enters Collaboration and Option Agreement With ADC Therapeutics
10 Oct 2019 UCB agrees to acquire Ra Pharmaceuticals: Joining forces to improve treatment options for people living with myasthenia gravis and other rare diseases
09 Oct 2019 bluebird bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases
08 Oct 2019 GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies
08 Oct 2019 Prevail Therapeutics and Lonza Establish Strategic Collaboration to Develop and Manufacture Prevail's Novel AAV9 Gene Therapy Programs for Patients with Neurodegenerative Diseases
08 Oct 2019 4D Pharma Collaborates With MSD to Develop Live Biotherapeutics for Vaccines
07 Oct 2019 Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-LRx
04 Oct 2019 Goldfinch Bio Announces Licensing Agreement with Takeda for CB1 Monoclonal Antibody for the Treatment of Rare and Metabolic Kidney Diseases
02 Oct 2019 Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company
02 Oct 2019 Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
01 Oct 2019 Sobi to acquire Dova Pharmaceuticals creating a global growth platform in haematology
01 Oct 2019 Numab and Eisai Enter Into a Global Research and Option Agreement to Discover and Develop Multi-Specific Antibody Immunotherapies for Cancer
01 Oct 2019 Tmunity Announces Exclusive License and Research Collaboration with Children’s Hospital of Philadelphia to Advance GPC2 CAR-T Cell Therapy for Neuroblastoma
01 Oct 2019 NewLink Genetics and Lumos Pharma Enter into Merger Agreement to Form Biopharmaceutical Company Focused on Developing Therapies to Treat Rare Diseases
01 Oct 2019 Bayer and Arvinas Unveil Targeted Protein Degradation Joint Venture, Oerth Bio
30 Sep 2019 Vertex and Ribometrix Establish Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
27 Sep 2019 Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform
27 Sep 2019 Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program Evaluating Ruxolitinib Cream in Patients with Vitiligo
27 Sep 2019 Harvard University Establishes mRna Immunotherapy Research Collaboration With Moderna
25 Sep 2019 Evotec and Takeda enter collaboration agreement to discover clinical candidates across multiple therapeutic areas
24 Sep 2019 Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
24 Sep 2019 Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals
20 Sep 2019 Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up